版本:
中国

BRIEF-Axovant Sciences appoints David Hung as CEO

April 10 Axovant Sciences Ltd

* Axovant Sciences announces appointment of Dr. David Hung as chief executive officer and expansion of board of directors

* Axovant Sciences Ltd - Mindset study results for intepirdine in mild-to-moderate Alzheimer's disease expected in late September 2017

* Axovant Sciences Ltd says Mindset study results for intepirdine in mild-to-moderate Alzheimer's disease expected in late September 2017

* Vivek Ramaswamy to remain on board of directors and assume full-time role as CEO of parent company Roivant sciences

* Axovant Sciences Ltd- also announced appointment of Marion Mccourt as president and chief operating officer

* Axovant Sciences Ltd - Hung, who also joined Axovant's board of directors, succeeds founding chief executive officer Vivek Ramaswamy

* Former medivation directors Kate Falberg and Tony Vernon appointed to board of directors

* Axovant Sciences Ltd - David Hung has been named chief executive officer of Axovant Sciences, effective April 7, 2017 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐